Workers' compensation experience in some Indigenous Northern Ontario communities.

Background: There is a dearth of research about occupational health and safety experience in Indigenous communities and compensation applications from Indigenous workers appear limited.

Objective: This qualitative descriptive study was designed to explore workers' compensation experiences in some Canadian Indigenous communities.

Methods: A community-based participatory research approach was used to conduct focus groups (n = 25 participants) in three Northeastern Ontario (NEO) Indigenous communities and at one NEO Indigenous employment centre.

Reorganization of motor system in Parkinson's disease.

Background/aims: We investigated adaptive reorganization in Parkinson's disease (PD) by fMRI using a passive movement task and compared the brain activation patterns of 10 patients with left- versus right-sided dominant symptoms. Five healthy controls were also investigated with the same settings.

Methods: We grouped patients according to the predominant side of symptoms; thus, a right-sided dominant and a left-sided dominant group was formed.

The role of burnout among Hungarian nurses.

This study was aimed to explore the occurrence of burnout among nurses in health and social institutions in Baranya County of Hungary, to reveal the connections between burnout and sociodemographic factors, and to learn its extent in different types of care. The survey was a one-off, representative sample with 805 questionnaires processed. The questionnaire was an internationally used and accepted standard paper designed for assessing burnout syndrome.

Acenocoumarol is not a safe alternative for anticoagulation in phenprocoumon-induced hepatic failure. Report of two cases.

Acenocoumarol has been proposed repeatedly as a safe alternative drug regimen for oral anticoagulation in patients who have suffered phenprocoumon-induced fulminant hepatic failure. The current report describes 2 patients with phenprocoumon-induced hepatic failure, necessitating liver transplantation in 1 case, who showed recurrence of liver damage when oral anticoagulation with acenocoumarol was attempted. Thus, acenocoumarol may not be a safe therapeutic alternative for patients who survived severe phenprocoumon-induced hepatotoxicity.